18+

CELLIVITY / ADULT ACCESS

Are you 18 or older?

CELLIVITY is available to adults only. Supplement pages are general product information; peptide records are not a sales offer and are not for human use.

Age confirmation is a declaration, not identity verification. Restricted research access still requires separate professional eligibility checks.Privacy and legal notice ↗
Skip to content
CELLIVITY
HomeScience LibraryEvidence methodologyResearch Radar
🇬🇧EN⌄
🇬🇧EnglishEN🇭🇺MagyarHU🇹🇭ไทยTH🇷🇺РусскийRU
Independent evidence
HomeScience LibraryEvidence methodologyResearch Radar
← Science Library

Mitochondria

Coenzyme Q10

CoQ10 · Ubiquinone · Ubiquinol

Packet question: fatigue, physical function, exercise performance and healthy agingEvidence level C

Level C describes limited, mixed or context-dependent human evidence for this exact question; read the conclusion for direction and limits.

This C grade applies only to the controlling packet question. Outcome grades below are more specific; neither the packet grade nor an outcome grade is an ingredient-wide or finished-product grade.
REVIEWED EVIDENCE PACKETQuestion-specific review complete for this published scope.

The grade is controlled by the stated packet question and outcome map.

IN PLAIN LANGUAGE

Why people are interested

CoQ10 is part of mitochondrial energy-transfer biology, but that role does not guarantee more energy in daily life. Human trials raise blood CoQ10 more reliably than they improve fatigue, performance or physical function.

Outcome map

One ingredient. Different questions.

Evidence can be stronger for a specific marker or population and weaker for a broader promise. Each row answers a separate question.

  1. 01

    Circulating CoQ10

    Oral supplementation reliably raises blood CoQ10 in the included trials, but a higher blood level does not prove a functional benefit.

    Evidence level B
  2. 02

    Fatigue in generally healthy adults

    The pooled evidence is heterogeneous, the healthy-adult subgroup remains compatible with no effect, and clinical importance is uncertain.

    Evidence level C
  3. 03

    Objective exercise performance

    Average performance effects are small and unstable; the clearest acute-analysis result did not show a performance boost.

    Evidence level C
  4. 04

    Diagnosed heart failure

    Selected mortality and hospitalization signals belong only to adults with diagnosed heart failure receiving clinical care, not healthy adults.

    Evidence level B
  5. 05

    Healthy aging and lifespan

    No direct qualifying human evidence shows that CoQ10 slows biological aging, delays disability or extends life.

    Evidence level E
Library trackFoundation topic
Last reviewed22 Aug 2026
Guide scopeIngredient research only
01

How it may work

Participates in mitochondrial electron transport and redox biology; a mechanistic role does not by itself prove greater energy, function or longevity.

02

What people have studied

Oral CoQ10 raises circulating CoQ10 in the included trials, but the pooled fatigue signal is heterogeneous and is not established as clinically meaningful in healthy adults. Objective performance and older-adult physical-function effects are small, unstable or context-specific, and no direct human evidence shows slower aging or longer life.

03

What to consider

Short trials are broadly reassuring but cannot establish universal or long-term safety. Official sources flag possible digestive effects and interactions with warfarin, glucose-lowering treatment and some cancer care.

04

Local pathway

Market-specific classification, source, strength, claims and finished product require separate local review.

Sources + indexes

See where the explanation comes from.

Open the linked research and official records behind this guide. Early topics may begin with a research index while stronger sources are added.

  1. 01CoQ10 and fatigue — systematic review and meta-analysis ↗
  2. 02CoQ10 blood levels and exercise performance — 2026 systematic review ↗
  3. 03Plasma versus muscle and functional outcomes in older adults ↗
  4. 04CoQ10 plus HIIT in older adults — small randomized trial ↗
  5. 05Selected statin-asthenia trial and its limitations ↗
  6. 06Cochrane — CoQ10 for diagnosed heart failure ↗
  7. 07High-dose CoQ10 in early Parkinson disease — phase III trial ↗
  8. 08NCCIH — Coenzyme Q10 safety and interactions ↗
  9. 09NCI — Coenzyme Q10 evidence and cancer-care context ↗
CELLIVITY

Independent evidence guides for human research.

Science LibraryHomeScience LibraryEvidence methodologyResearch Radar
BoundariesLegal and privacySafety boundariesPrivacy request / unsubscribe
Pre-release boundary

Unless a page explicitly says released, every product is a development record. No page confirms approval, stock, individual suitability or medical benefit. Educational content is not medical advice.

Full legal terms →
© 2026 CELLIVITY. Pre-launch.Riviera Jomtien, 29/111, Pattaya 20150, ThailandControlled contact route

CELLIVITY / STAY IN THE LOOP

Follow the next
chapter.

New product records, laboratory documents and release news. Choose to hear from us when there is something useful to share.

  • New laboratory documents
  • Product availability updates
  • News from CELLIVITY
18+ only. Optional email updates. You can unsubscribe at any time.
Coenzyme Q10 — CELLIVITY Science Library